A phase IB open-label, multicenter study evaluating the safety, efficacy, and pharmacokinetics of mosunetuzumab in patients with relapsed or refractory chronic lymphocytic leukemia

Project: Research

Project Details

Project Description


StatusActive
Effective start/end date5/04/2213/02/27

Keywords

  • leukemia
  • treatment safety
  • treatment efficacy
  • multicentre trial
  • phase 1 study